Medtronic (MDT) Reports First Patient Enrollment in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery
Tweet Send to a Friend
Medtronic plc (NYSE: MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
